Technical Data
D2675-02A
Deleted in Azoospermia-Like (DAZL, DAZL1, DAZ Homolog, DAZH, DAZ-like Autosomal, DAZLA, MGC26406, SPGY-like-autosomal, SPGYLA)
Description:
DAZL is involved in mitosis and meiosis of human germ cells. The DZL gene family encodes potential RNA binding proteins that are expressed in prenatal and postnatal germ cells of diverse mammalian species. The protein encoded by this gene is localized to the nucleus and cytoplasm of fetal germ cells and to the cytoplasm of developing oocytes. In humans, DZL is expressed in primordial germ cells, adult testis, and the ovary. It plays a central role during spermatogenesis. Defects in DZL may cause infertility due to severe oligozoospermia (az) and non obstructive azoospermia. The concentrations of DZL transcripts were found to be lower in men with spermatogenic failure. Drosophila and mouse mutants that have lost DZL homologous gene function found to be azoospermic, just as with human azoospermia.

Applications:
Suitable for use in ELISA. Other applications not tested.

Recommended Dilution:
ELISA: 1:100-1:1000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGSerum
SizeStorageShippingSourceHost
100ul-20CBlue IceHumanRabbit
Concentration:
Not determined.
Immunogen:
Synthetic peptide corresponding to aa261-275 (NPENRLRNSVVTQDD) of human DAZL.
Purity:
Serum
Form
Supplied as a liquid, 0.025% sodium azide, 50% glycerol.
Specificity:
Recognizes human DAZL. Species Crossreactivity: chimpanzee, bovine, equine. Species sequence homology: chicken, canine, monkey, mouse, rat.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Kuo, PL. et.al Fertil. Steril. 81:1034-1040 (2004). 2. Brekhman, V. et al. Mol. Hum. Reprod. 6:465-468 (2000). 3. Teng, YN. et al. J. Clin. Endocr. Metab. 87:5258-5264 (2002).